Guardant Health Inc (GH)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$127.15
Buy
$131.00
$-3.53 (-2.65%)
Prices updated at 30 May 2026, 00:58 EDT
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Dr. Helmy Eltoukhy, PhD
CEO
Dr. AmirAli Talasaz, PhD
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
2,506
Head office
3100 Hanover Street
Palo Alto
United States
94304
Key personnel
Owner name | Salary |
|---|---|
Mr. Alex M. Azar,II Independent Director | - |
Mr. Ian T. Clark Lead Independent Director | - |
Ms. Myrtle S. Potter Independent Director | - |
Ms. Vijaya Gadde Independent Director | - |
Ms. Terilyn Juarez Monroe Chief People Officer | - |
Mr. Steven E. Krognes, M.B.A. Independent Director | - |
Mr. John G. Saia Chief Legal Officer and Corporate Secretary | 0.53m |
Mr. Michael Brian Bell Chief Financial Officer and Principal Accounting Officer | 0.57m |
Mr. Roberto A. Mignone Independent Director | - |
Dr. Helmy Eltoukhy, PhD Co-Chief Executive Officer and Chairman of the Board | 0.00m |
Dr. AmirAli Talasaz, PhD Co-Chief Executive Officer and Director | 0.00m |
Ms. Meghan V. Joyce Independent Director | - |
Dr. Manuel Hidalgo Medina, M.D.,PhD Independent Director | - |
Mr. Kumud Kalia Chief Information Officer | - |
Mr. Christopher Freeman Chief Commercial Officer | - |
Mr. Musa Tariq Independent Director | - |
Ms. Darya Chudova Chief Technology Officer | 0.52m |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 12,160,768 |
| BlackRock Inc | 11,553,759 |
| T. Rowe Price Associates, Inc. | 7,023,689 |
| Fidelity Management & Research Company LLC | 5,473,002 |
| Amvescap Plc. | 4,946,469 |
Director dealings
Date | Action |
|---|---|
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 01 Jan 2026 | - |
| 01 Jan 2026 | - |
| 01 Jan 2026 | - |
| 31 Dec 2025 | - |
| 01 Jan 2026 | - |
| 31 Dec 2025 | - |
| 01 Jan 2026 | - |
| 01 Jan 2026 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
| 31 Dec 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
